PatientsLikeMe ™

MS
Join Now (It's free!)

Already a member? Log in

Share your real-world treatment experience
with patients just like you.
Select a community
MS
Find out more about the PatientsLikeMe
MS Community

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


What is Frova? Frova is a brand name for the drug Frovatriptan, a triptan drug used in the treatment of migraine headaches. Frova is a brand name owned by Vernalis. Read more...Click to read more below

See more information, including instructions, precautions, side effects, and interactions.

Vernalis's Frova site


Reasons Taken

2 patients in the community are taking or have taken Frova.

Reason # Patients Percentage of patients
Other 2 100%

Dosages

Based on the patients currently taking Frova.

  2.5 mg Daily
  1 Number of Patients: 1  

Duration

How long current patients have been taking Frova or how long patients were taking Frova before stopping.

Currently taking Frova

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0
1

Patient Reported Evaluations

Results from 1 patient evaluation. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Moderate 100% 1

Other

Side-effects (as an overall problem)

Severe 0% 0
Moderate 0% 0
Mild 0% 0
None 100% 1

Top reported side-effects include:

Summary results are based on 1 individual response. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (1 of 1)

  • dbrister
    Sex: F
    Sensation: Moderate
    Overall: Mild
    Cognition: moderate
    Vision: mild
    Speech: mild
    Swallowing: mild
    Upper limb: moderate
    Walking: moderate
  • dbrister
  • by dbrister
    Sep 04, 2008
  • EfficacyModerate
  • Side-effectsNone
  • Other
Advice/Tips
My doctor wrote a medical exception letter when I needed more pills than my insurance would cover for a one month supply.

See all evaluation results for Frova



Back to top